Homeostatic and Tissue Reparation Defaults in Mice Carrying Selective Genetic Invalidation of CXCL12/Proteoglycan Interactions
Authors:
- Patricia RuedaPRPatricia Rueda
- Adèle RichartARAdèle Richart
- Alice RécaldeARAlice Récalde
- Pamela GassePGPamela Gasse
- José VilarJVJosé Vilar
- Coralie GuérinCGCoralie Guérin
- Hugues Lortat-JacobHLHugues Lortat-Jacob
- Paulo VieiraPVPaulo Vieira
- Frano̧iSe BaleuxFBFrano̧iSe Baleux
- Fabrice ChretienFCFabrice Chretien
- Fernando Arenzana-SeisdedosFAFernando Arenzana-Seisdedos
- Jean-Sébastien SilvestreJSJean-Sébastien Silvestre
- 9 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 126 (15) , 1882-1895
Abstract
Background—: Interaction with heparan sulfate proteoglycans is supposed to provide chemokines with the capacity to immobilize on cell surface and extracellular matrix for accomplishing both tissue homing and signaling of attracted cells. However, the consequences of the exclusive invalidation of such interaction on the roles played by endogenous chemokines in vivo remain unascertained. Methods and Results—: We engineered a mouse carrying a Cxcl12 gene ( Cxcl12 Gagtm ) mutation that precludes interactions with heparan sulfate structures while not affecting CXCR4-dependent cell signaling of CXCL12 isoforms (α, β, γ). Cxcl12 Gagtm/Gagtm mice develop normally, express normal levels of total and isoform-specific Cxcl12 mRNA, and show increased counting of circulating CD34 + hematopoietic precursor cells. After induced acute ischemia, a marked impaired capacity to support revascularization was observed in Cxcl12 Gagtm/Gagtm animals associated with a reduced number of infiltrating cells in the ischemic tissue despite the massive expression of CXCL12 isoforms. Importantly, exogenous administration of CXCL12γ, which binds heparan sulfate with the highest affinity ever reported for a cytokine, fully restores vascular growth, whereas heparan sulfate–binding CXCL12γ mutants failed to promote revascularization in Cxcl12 Gagtm/Gagtm animals. Conclusion—: These findings prove the role played by heparan sulfate interactions in the functions of CXCL12 in both homeostasis and physiopathological settings and document for the first time the paradigm of chemokine immobilization in vivo.Keywords
This publication has 50 references indexed in Scilit:
- Endothelial Heparan Sulfate Controls Chemokine Presentation in Recruitment of Lymphocytes and Dendritic Cells to Lymph NodesImmunity, 2010
- Immobilized Chemokine Fields and Soluble Chemokine Gradients Cooperatively Shape Migration Patterns of Dendritic CellsImmunity, 2010
- Anti‐inflammatory therapy by intravenous delivery of non‐heparan sulfate‐binding CXCL12The FASEB Journal, 2009
- Integrins in angiogenesis and lymphangiogenesisNature Reviews Cancer, 2008
- The Novel CXCL12γ Isoform Encodes an Unstructured Cationic Domain Which Regulates Bioactivity and Interaction with Both Glycosaminoglycans and CXCR4PLOS ONE, 2007
- Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Proceedings of the National Academy of Sciences, 2007
- PSGL-1–mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cellsJournal of Clinical Investigation, 2007
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJournal of Experimental Medicine, 2006
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996